Kolexia
Berda-Haddad Yael
Pharmacien
Hôpital La Conception
Marseille, France
43 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Leucémie aigüe myéloïde Leucémies Lymphomes Syndrome d'activation macrophagique Pancytopénie Lymphohistiocytose hémophagocytaire Polyglobulie primitive essentielle Leucémie myéloïde COVID-19

Industries

Sanofi
6 collaboration(s)
Dernière en 2023
Janssen
4 collaboration(s)
Dernière en 2022
Novartis
2 collaboration(s)
Dernière en 2022
Pfizer
1 collaboration(s)
Dernière en 2022

Dernières activités

Cytological Diagnosis of Classic Myeloproliferative Neoplasms at the Age of Molecular Biology.
Cells   20 mars 2023
Determination of 5-azacitidine in human plasma by LC-MS/MS: application to pharmacokinetics pilot study in MDS/AML patients.
Cancer chemotherapy and pharmacology   01 mars 2023
Pharmacokinetics and pharmacogenetics of liposomal cytarabine in AML patients treated with CPX-351.
Journal of controlled release : official journal of the Controlled Release Society   18 août 2021
Landing disease: a surprising cytological diagnosis on day 2 of life.
Blood   30 juillet 2021
Could daratumumab induce the maturation of plasmablasts in Plasmablastic lymphoma?-Potential therapeutic applications.
European journal of haematology   02 février 2021
Severe and Irreversible Pancytopenia Associated With SARS-CoV-2 Bone Marrow Infection in a Patient With Waldenstrom Macroglobulinemia.
Clinical lymphoma, myeloma & leukemia   13 janvier 2021
Circulating Endothelial Cells as a Marker of Endothelial Injury in Severe COVID -19.
The Journal of infectious diseases   17 décembre 2020
Automated red blood cell depletion: Results from a validation trial of the Fenwal Amicus new red blood cell depletion program.
Journal of clinical apheresis   03 juillet 2020
Different sensitivity of CD19-positive bone marrow and lymph node lymphoblasts may cause resistance to blinatumomab in relapsed B-cell acute lymphoblastic leukemia/lymphoma.
Leukemia & lymphoma   03 janvier 2020
Simultaneous determination of cytosine arabinoside and its metabolite uracil arabinoside in human plasma by LC-MS/MS: Application to pharmacokinetics-pharmacogenetics pilot study in AML patients.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences   19 août 2019